AU5977700A - Vaccines - Google Patents
VaccinesInfo
- Publication number
- AU5977700A AU5977700A AU59777/00A AU5977700A AU5977700A AU 5977700 A AU5977700 A AU 5977700A AU 59777/00 A AU59777/00 A AU 59777/00A AU 5977700 A AU5977700 A AU 5977700A AU 5977700 A AU5977700 A AU 5977700A
- Authority
- AU
- Australia
- Prior art keywords
- vaccines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9915204.3A GB9915204D0 (en) | 1999-06-29 | 1999-06-29 | Vaccine |
GB9915204 | 1999-06-29 | ||
PCT/EP2000/005841 WO2001000231A2 (fr) | 1999-06-29 | 2000-06-23 | Vaccins |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5977700A true AU5977700A (en) | 2001-01-31 |
Family
ID=10856286
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU59777/00A Abandoned AU5977700A (en) | 1999-06-29 | 2000-06-23 | Vaccines |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1198243A2 (fr) |
AU (1) | AU5977700A (fr) |
CA (1) | CA2376926A1 (fr) |
GB (1) | GB9915204D0 (fr) |
HK (1) | HK1047034A1 (fr) |
WO (1) | WO2001000231A2 (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
SI1077722T1 (sl) | 1998-05-22 | 2007-02-28 | Ottawa Health Research Inst | Metode in produkti za induciranje sluznicne imunosti |
GB9908885D0 (en) * | 1999-04-19 | 1999-06-16 | Smithkline Beecham Biolog | Vccine |
US7129222B2 (en) | 2000-03-10 | 2006-10-31 | Dynavax Technologies Corporation | Immunomodulatory formulations and methods for use thereof |
US20030129251A1 (en) | 2000-03-10 | 2003-07-10 | Gary Van Nest | Biodegradable immunomodulatory formulations and methods for use thereof |
WO2002058727A2 (fr) * | 2001-01-26 | 2002-08-01 | Walter Reed Army Institute Of Research | Vaccin a base de proteine 142 de merozoite p.falciparum de recombinaison |
US7306806B2 (en) | 2001-01-26 | 2007-12-11 | United States Of America As Represented By The Secretary Of The Army | Recombinant P. falciparum merozoite protein-142 vaccine |
AU2001281267B2 (en) * | 2001-08-10 | 2008-05-15 | Dynavax Technologies Corporation | Immunomodulatory oligonnucleotide formulations and methods for use thereof |
CA2388049A1 (fr) | 2002-05-30 | 2003-11-30 | Immunotech S.A. | Oligonucleotides immunostimulateurs et utilisations connexes |
US20070104726A1 (en) * | 2002-08-14 | 2007-05-10 | Avidis Sa | Multimeric complexes of antigens and adjuvants |
JP4199988B2 (ja) * | 2002-11-14 | 2008-12-24 | 大日本印刷株式会社 | 化粧シート |
PL2066344T3 (pl) | 2006-09-07 | 2011-10-31 | Glaxosmithkline Biologicals Sa | Skojarzona szczepionka zawierająca inaktywowany wirus polio |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69228698T2 (de) * | 1991-11-16 | 1999-09-16 | Smithkline Beecham Biologicals S.A., Rixensart | HYBRIDES PROTEIN ZWISCHEN CS AUS PLASMODIUM UND HBsAG |
ATE420171T1 (de) * | 1994-07-15 | 2009-01-15 | Univ Iowa Res Found | Immunomodulatorische oligonukleotide |
GB9616351D0 (en) * | 1996-08-02 | 1996-09-11 | Smithkline Beecham Biolog | Vaccine composition |
US6214806B1 (en) * | 1997-02-28 | 2001-04-10 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CPC dinucleotide in the treatment of LPS-associated disorders |
PT1005368E (pt) * | 1997-03-10 | 2009-11-19 | Coley Pharm Gmbh | Utilização de ácidos nucleicos contendo dinucleótidos cpg não metilados em combinação com alúmen como adjuvante |
DE69815692T2 (de) * | 1997-09-05 | 2004-04-29 | Glaxosmithkline Biologicals S.A. | Öl in wasser emulsionen mit saponinen |
CA2347099C (fr) * | 1998-10-16 | 2014-08-05 | Smithkline Beecham Biologicals S.A. | Systemes d'adjuvants comprenant un immunostimulant absorbe sur une particule de sel metallique et vaccins derives |
IL145982A0 (en) * | 1999-04-19 | 2002-07-25 | Smithkline Beecham Biolog | Vaccines |
-
1999
- 1999-06-29 GB GBGB9915204.3A patent/GB9915204D0/en not_active Ceased
-
2000
- 2000-06-23 EP EP00945810A patent/EP1198243A2/fr not_active Ceased
- 2000-06-23 CA CA002376926A patent/CA2376926A1/fr not_active Abandoned
- 2000-06-23 AU AU59777/00A patent/AU5977700A/en not_active Abandoned
- 2000-06-23 WO PCT/EP2000/005841 patent/WO2001000231A2/fr active Application Filing
-
2002
- 2002-09-26 HK HK02107137.7A patent/HK1047034A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
EP1198243A2 (fr) | 2002-04-24 |
CA2376926A1 (fr) | 2001-01-04 |
HK1047034A1 (zh) | 2003-02-07 |
WO2001000231A3 (fr) | 2001-07-05 |
GB9915204D0 (en) | 1999-09-01 |
WO2001000231A2 (fr) | 2001-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0202885A3 (en) | Vaccines | |
AU1173201A (en) | Skin-gripper | |
AU3092999A (en) | Digital-timeshare-exchange | |
AU3198200A (en) | Prrsv vaccines | |
AU6600300A (en) | Pneumococcal vaccines | |
AU5967600A (en) | Candystraw | |
AU5977700A (en) | Vaccines | |
GB9901254D0 (en) | Vaccines | |
AU7514700A (en) | Cyanopiperidines | |
AU4115400A (en) | Short-circuiter | |
AU6335000A (en) | Depthimeter | |
AU6440900A (en) | Homogentisate-dioxygenase | |
AU2804600A (en) | Arylaminoalkylamides | |
AU2023701A (en) | Sketcher | |
AU2699800A (en) | Organoceramics | |
AU6158700A (en) | Vaccine | |
AU6098300A (en) | Follistatin-3 | |
AU4916900A (en) | Benzofuranylsulfonates | |
AU4561600A (en) | Benzofuranylaminoalcohols | |
AU1901801A (en) | Glucofuranoses | |
AU5811600A (en) | Vaccine | |
AU4435300A (en) | Hula-hoop | |
AU1915601A (en) | Periotome | |
AU7513400A (en) | Hydantoin-racemase | |
AU7303400A (en) | Osseo-distractor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |